Gian Life Care Ltd
GIANLIFEGian Life Care Ltd
GIANLIFE
Price Chart
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 15.84 | 1.43 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 64.32 | 10.30 | 0.27% |
Forecast & Ratings
Detailed ForecastPrice
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Gian Life Care Limited is an India-based company primarily engaged in the business of providing diagnostic and related healthcare tests and services. The Company provides a range of diagnostic and related healthcare tests and services such as patient diagnosis services and prevention and wellness diagnosis services to patients and healthcare providers. The Company is focused on opening several diagnostics labs in various parts of the State. Its customers include individual patients, hospitals, other healthcare providers and corporate customers.
Peers
Compare with peersPREVEST DENPRO LTD
Asarfi Hospital Ltd
Hemant Surgical Industries Ltd
Aashka Hospitals Ltd
KK Shah Hospitals Limited
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | TTM | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.56 | 7.75 | 10.75 | 16.44 | 12.62 | 12.01 | ||||||
Raw Materials | 0.07 | 0.00 | 0.00 | 0.00 | 10.10 | 9.14 | ||||||
| Power & Fuel Cost | 0.01 | 0.16 | 0.17 | 0.24 | ||||||||
| Employee Cost | 0.11 | 1.02 | 0.94 | 1.31 | ||||||||
| Selling & Administrative Expenses | 0.16 | 2.67 | 2.55 | 3.66 | ||||||||
| Operating & Other expenses | 0.02 | 1.72 | 3.69 | 4.66 | ||||||||
EBITDA | 0.19 | 2.18 | 3.40 | 6.57 | 2.52 | 2.87 | ||||||
| Depreciation/Amortization | 0.02 | 0.26 | 0.29 | 0.33 | 0.50 | 0.52 | ||||||
| PBIT | 0.17 | 1.92 | 3.11 | 6.24 | 2.02 | 2.35 | ||||||
| Interest & Other Items | 0.04 | 0.37 | 0.35 | 0.39 | 0.43 | 0.46 | ||||||
| PBT | 0.13 | 1.55 | 2.76 | 5.85 | 1.59 | 1.89 | ||||||
| Taxes & Other Items | 0.03 | 0.44 | 0.74 | 1.48 | 0.53 | 0.62 | ||||||
| Net Income | 0.10 | 1.11 | 2.02 | 4.37 | 1.06 | 1.27 | ||||||
| EPS | 0.10 | 1.11 | 1.95 | 4.23 | 1.03 | 1.23 | ||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Peers & Comparison
Healthcare
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Gian Life Care Ltd | 18.98 | 1.43 | — |
| PREVEST DENPRO LTD | 33.03 | 7.12 | 0.23% |
| Asarfi Hospital Ltd | 24.12 | 4.62 | — |
| Hemant Surgical Industries Ltd | 22.77 | 7.38 | — |
Price Comparison
Compare GIANLIFE with any stock or ETFShareholdings
Promoter Holdings Trend
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
GIANLIFE has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Hmm, looks like data is unavailable here. Please come back after some timeNews & Opinions
Hmm, looks like data is unavailable here. Please come back after some time.
Decreased Total Promoter Holding
In last 6 months, promoter holding in the company has decreased by 3.80%
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant